AÏDA ONCOLOGY Aps: Financial statements 2025
CVR: 42246468
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
AÏDA ONCOLOGY Aps (CVR 42246468) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,913,891 and a net result of DKK -5,579,964 compared with DKK -2,613,422 the year before. Equity in the 2025 report amounted to DKK -10,698,205. The company had 5 employees in the financial year.
- Gross Profit
- DKK -1,913,891
- Profit/Loss
- DKK -5,579,964
- Equity
- DKK -10,698,205
- Total Assets
- DKK 8,343,865
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -1.9 mio. | -5.6 mio. | -10.7 mio. | 5 |
| 2024 | - | -2.4 mio. | -2.6 mio. | -5.1 mio. | 2 |
| 2023 | - | -2.2 mio. | -2.4 mio. | -2.5 mio. | 1 |
| 2022 | 0 | -179 t. | -180 t. | -145 t. | - |
Official annual report
How creditworthy is AÏDA ONCOLOGY Aps?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
AÏDA ONCOLOGY Aps has published its annual report for 2024. Gross profit came to DKK -2,408,961, and the net result was DKK -2,613,422.
About AÏDA ONCOLOGY Aps
AÏDA ONCOLOGY Aps is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ulla Hald Buhl and Claus Frisenberg Pedersen. The board consists of Neil Goldsmith (chair), Claus Frisenberg Pedersen, Peter Buhl and Ulla Hald Buhl. The company's owners include Ida Kappel Buhl, BUHL KRONE HOLDING ApS and Arrow Strategy Holding 2 ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -1,913,891 and a net result of DKK -5,579,964 compared with DKK -2,613,422 the year before. Equity in the 2025 report amounted to DKK -10,698,205.